Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
DCGO 
DocGo Inc (DCGO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/06/2026: DCGO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $2.5
1 Year Target Price $2.5
| 3 | Strong Buy |
| 1 | Buy |
| 3 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -41.26% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/06/2026 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 87.43M USD | Price to earnings Ratio - | 1Y Target Price 2.5 |
Price to earnings Ratio - | 1Y Target Price 2.5 | ||
Volume (30-day avg) 7 | Beta 0.94 | 52 Weeks Range 0.86 - 5.67 | Updated Date 01/6/2026 |
52 Weeks Range 0.86 - 5.67 | Updated Date 01/6/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.53 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -14.02% | Operating Margin (TTM) -35.64% |
Management Effectiveness
Return on Assets (TTM) -9.47% | Return on Equity (TTM) -21.07% |
Valuation
Trailing PE - | Forward PE 60.24 | Enterprise Value 42966613 | Price to Sales(TTM) 0.24 |
Enterprise Value 42966613 | Price to Sales(TTM) 0.24 | ||
Enterprise Value to Revenue 0.12 | Enterprise Value to EBITDA 5.57 | Shares Outstanding 97813372 | Shares Floating 90265114 |
Shares Outstanding 97813372 | Shares Floating 90265114 | ||
Percent Insiders 7.62 | Percent Institutions 50.65 |
Upturn AI SWOT
DocGo Inc
Company Overview
History and Background
DocGo Inc. was founded in 2015 as an evolution of its predecessor, Ambulatory Healthcare Services, Inc., which was established in 2007. The company has focused on leveraging technology to transform healthcare delivery, moving services from traditional hospital settings to patients' homes. A significant milestone was its rebranding to DocGo and its subsequent IPO in 2021, enabling further expansion and investment in its technology platform and service offerings.
Core Business Areas
- On-Demand Mobile Healthcare Services: DocGo provides a suite of on-demand healthcare services delivered directly to patients' homes, workplaces, or other locations. This includes emergency medical services (EMS), basic medical care, diagnostic testing, and chronic care management, all facilitated by a mobile app and proprietary technology platform.
- Technology Platform: The company's proprietary technology platform is central to its operations, enabling efficient scheduling, dispatch, patient engagement, data management, and telehealth capabilities. This platform integrates with electronic health records (EHRs) and other healthcare systems.
- Partnerships and Enterprise Solutions: DocGo collaborates with hospitals, health systems, insurance providers, and employers to offer tailored healthcare solutions that reduce hospital readmissions, improve patient outcomes, and lower healthcare costs.
Leadership and Structure
DocGo is led by a management team with experience in healthcare, technology, and operations. The organizational structure is designed to support its integrated model of mobile healthcare delivery and technology development, with dedicated teams for operations, technology, sales, and clinical services.
Top Products and Market Share
Key Offerings
- Product Name 1: On-Demand Mobile EMS & Medical Services. This includes transport, basic medical assessment and treatment, and in-home care. Market share is difficult to pinpoint as it's an evolving segment, but competitors include traditional ambulance services and emerging home-based care providers. Revenue is generated through service fees, insurance reimbursements, and partnership agreements. Competitors: American Medical Response (AMR), MASA Medical Transport, various local EMS providers, and telehealth platforms offering remote consultations.
- Product Name 2: DocGo Health Platform. This proprietary technology suite offers patient-facing mobile applications for booking and managing care, provider-facing tools for dispatch and clinical support, and analytics for operational efficiency. Market share is nascent, as it's a key differentiator rather than a standalone product sold externally. Competitors: EHR providers with patient portals, telehealth platforms like Teladoc, and specialized healthcare logistics software companies.
Market Dynamics
Industry Overview
DocGo operates in the rapidly growing fields of telehealth, home-based healthcare, and mobile healthcare delivery. The industry is driven by a demand for convenient, accessible, and cost-effective healthcare solutions, particularly for aging populations and individuals with chronic conditions. Technological advancements in connectivity and digital health tools are enabling new models of care.
Positioning
DocGo is positioned as a technology-enabled provider of on-demand mobile healthcare services. Its key competitive advantages include its integrated technology platform, which allows for efficient operations and scalability, and its ability to deliver a comprehensive range of medical services directly to patients. The company aims to differentiate itself by offering a more holistic and patient-centric approach compared to traditional healthcare models.
Total Addressable Market (TAM)
The total addressable market for on-demand mobile healthcare and telehealth services is substantial and rapidly expanding. Estimates vary, but the global telehealth market alone is projected to reach hundreds of billions of dollars in the coming years. DocGo is positioned to capture a significant portion of this TAM by offering a blend of in-person mobile services and digital health solutions, addressing a broad spectrum of patient needs.
Upturn SWOT Analysis
Strengths
- Proprietary technology platform enabling efficient operations and scalability.
- Integrated model of mobile healthcare delivery and technology.
- Focus on patient convenience and accessibility.
- Experienced management team.
- Growing demand for home-based and on-demand healthcare.
Weaknesses
- Reliance on reimbursement from insurance providers and government programs.
- Operational challenges in scaling a mobile workforce.
- Brand recognition and market penetration may be limited compared to established healthcare providers.
- High upfront investment in technology and infrastructure.
- Potential regulatory hurdles and compliance complexities.
Opportunities
- Expansion into new geographic markets.
- Development of new service lines and care models.
- Strategic partnerships with health systems, payers, and employers.
- Leveraging AI and machine learning for predictive analytics and personalized care.
- Increasing adoption of digital health solutions by patients and providers.
Threats
- Increased competition from existing and new players in the telehealth and home healthcare space.
- Changes in healthcare regulations and reimbursement policies.
- Cybersecurity risks and data breaches.
- Economic downturns impacting healthcare spending.
- Difficulty in attracting and retaining qualified clinical staff.
Competitors and Market Share
Key Competitors
- American Medical Response (AMR) (Envision Healthcare)
- Guardian Health Systems
- Rural Metro Fire and EMS
- Amwell (AMWL)
- Teladoc Health (TDOC)
Competitive Landscape
DocGo differentiates itself through its integrated technology platform and its focus on providing on-demand, in-person mobile healthcare services combined with digital capabilities. While traditional EMS providers and large telehealth platforms exist, DocGo's niche lies in bridging the gap between in-person care and technological convenience. Its agility and focus on patient experience are potential advantages, but its scale compared to larger players like AMR and Amwell is a disadvantage.
Growth Trajectory and Initiatives
Historical Growth: DocGo has demonstrated significant historical revenue growth, driven by the expansion of its service offerings and geographic reach. The company has been focused on scaling its operations and increasing its customer base. (Specific historical revenue growth percentages would be required).
Future Projections: Future growth projections are typically based on analyst estimates, which consider market trends, company strategy, and competitive landscape. These projections often anticipate continued expansion of mobile healthcare services, adoption of technology, and strategic partnerships. (Analyst consensus estimates would need to be sourced).
Recent Initiatives: Recent initiatives likely include the expansion of its technology platform capabilities, strategic partnerships to broaden its reach, and potential new service offerings to meet evolving healthcare demands. The company has also focused on operational efficiency to improve profitability. (Specific recent initiatives would need to be detailed from company announcements).
Summary
DocGo Inc. is a promising player in the rapidly expanding mobile healthcare and telehealth market. Its integrated technology platform and focus on patient convenience are strong assets. However, the company faces challenges related to competition, regulatory changes, and the need for sustained profitability as it scales. Continued investment in technology and strategic partnerships will be crucial for its future success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company's SEC Filings (10-K, 10-Q)
- Investor Relations Websites
- Reputable Financial News Outlets
- Market Research Reports (where applicable and cited)
Disclaimers:
This JSON output is for informational purposes only and does not constitute financial advice. The information is based on publicly available data and general market analysis. Numerical data, especially financial metrics and market share, are subject to change and should be verified with official sources. Projections and future outlooks are speculative.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DocGo Inc
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2021-11-05 | CEO & Director Mr. Lee Bienstock | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 3404 | Website https://www.docgo.com |
Full time employees 3404 | Website https://www.docgo.com | ||
DocGo Inc. provides mobile health and medical transportation services in the United States and the United Kingdom. The company offers transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also provides mobile health services through its platform that are performed at home, offices, and other locations; event services, including on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was incorporated in 2015 and is headquartered in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.